Every two weeks, a clinician assesses progress and determines whether the dose should stay the same, increase slightly, or decrease based on how the body responds
2024;150(Suppl_1):A4113997-A4113997
Despite the potential of GLP-1RA plus SGLT2i combination therapy to improve metabolic-cardiovascular-renal trajectories, several factors may delay this combination to become a common practice soon, and most T2DM patients with ASCVD or at high ASCVD risk remain inadequately managed
What Helps Most (Simple Actions) Here are a few tips that help most people: Eat smaller meals more frequently throughout the day instead of three large ones to find the right dose for your needs
Supply constraints have periodically affected availability, with the FDA reporting shortages of several GLP-1 formulations throughout 2022-2024
Foods and supplements may claim to stimulate GLP-1, but its not the same. I take semaglutide for my pre-diabetes, which is nearly impossible to treat without medical intervention